1
Voorberg, Angelique N., Romeijn, Geertruida L.E., de Bruin-Weller, Marjolein S., Schuttelaar, Marie L.A.
Veröffentlicht in: Voorberg , A N , Romeijn , G L E , de Bruin-Weller , M S & Schuttelaar , M L A 2022 , ' The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis : 52 week results from the Dutch BioDay Registry ' , Contact Dermatitis , vol. 87 , no. 2 , pp. 185-191 . https://doi.org/10.1111/cod.14104;
2022
Veröffentlicht in: Voorberg , A N , Romeijn , G L E , de Bruin-Weller , M S & Schuttelaar , M L A 2022 , ' The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis : 52 week results from the Dutch BioDay Registry ' , Contact Dermatitis , vol. 87 , no. 2 , pp. 185-191 . https://doi.org/10.1111/cod.14104;
2022
2
3
4
Ariëns, Lieneke F.M., van der Schaft, Jorien, Spekhorst, Lotte S., Bakker, Daphne S., Romeijn, Geertruida L.E., Kouwenhoven, Tessa A., Kamsteeg, Marijke, Voorberg, Angelique N., Oosting, Albert J., de Ridder, Ilona, Sloeserwij, Annemieke, Haeck, Inge, Thijs, Judith L., Schuttelaar, Marie L.A., de Bruin-Weller, Marjolein S.
Veröffentlicht in: Ariëns , L F M , van der Schaft , J , Spekhorst , L S , Bakker , D S , Romeijn , G L E , Kouwenhoven , T A , Kamsteeg , M , Voorberg , A N , Oosting , A J , de Ridder , I , Sloeserwij , A , Haeck , I , Thijs , J L , Schuttelaar , M L A & de Bruin-Weller , M S 2021 , ' Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice : 52-Week results from the Dutch BioDay registry ' , Journal of the American Academy of Dermatology , vol. 84 , no. 4 , pp. e279-e280 . https://doi.org/10.1016/j.jaad.2020.08.127;
2021
Veröffentlicht in: Ariëns , L F M , van der Schaft , J , Spekhorst , L S , Bakker , D S , Romeijn , G L E , Kouwenhoven , T A , Kamsteeg , M , Voorberg , A N , Oosting , A J , de Ridder , I , Sloeserwij , A , Haeck , I , Thijs , J L , Schuttelaar , M L A & de Bruin-Weller , M S 2021 , ' Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice : 52-Week results from the Dutch BioDay registry ' , Journal of the American Academy of Dermatology , vol. 84 , no. 4 , pp. e279-e280 . https://doi.org/10.1016/j.jaad.2020.08.127;
2021